Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07389824
Clinical Trial
Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy and safety of acupuncture combined with mesalazine (an integrated acupuncture-medication regimen) for ulcerative colitis.
Trial Details
NCT Number
NCT07389824
Lead Sponsor
Qin Yu
Conditions
Ulcerative Colitis
Enrollment
80 participants
Start Date
2026-02-01
Primary Completion
2027-09-30
(estimated)
Study Completion
2027-12-31
(estimated)
Updated on ClinicalTrials.gov
2026-02-05